Empowered Funds’s Tandem Diabetes Care TNDM Stock Holding History

Empowered Funds’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-18,024	Closed	-$1.07M	–	160
2020 Q1	$1.07M	Hold	18,024	–	–	0.39%	101
2019 Q4	$1.07M	Buy	+18,024	New	+$1.11M	0.39%	101
2019 Q3	–	Sell	-17,155	Closed	-$1.11M	–	126
2019 Q2	$1.11M	Sell	17,155 -12,504	-42%	-$807K	0.46%	84
2019 Q1	$1.88M	Buy	+29,659	New	+$1.56M	0.67%	46

Other funds holding TNDM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Empowered Funds's TNDM Position: Q2 2020 in Review

Empowered Funds sold out of Tandem Diabetes Care (TNDM) in Q2 2020, closing a stake of 18,024 shares — an estimated $1.07M sold.

Empowered Funds first reported a position in TNDM in Q1 2019 and held it in 4 quarters. The position peaked at $1.88M in Q1 2019. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2020.

Empowered Funds reported no remaining Tandem Diabetes Care position as of Q2 2020 after selling out during the quarter.
Empowered Funds sold 18,024 Tandem Diabetes Care shares in Q2 2020, an estimated $1.07M.
Empowered Funds first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 4 quarters.
Empowered Funds's Tandem Diabetes Care position peaked at $1.88M in Q1 2019.
303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2020.

Based on Empowered Funds's 13F filing for Q2 2020, filed 16 Jul 2020.